Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in HBV infection and replication systems in vitro. | Virol J | 2021 | 34051803 | PubTator, text mining | PubMed |
| Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications. | Epilepsy Res | 2021 | 34044300 | PubTator, text mining | PubMed |
| In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions. | Toxicol Lett | 2021 | 34044055 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. | Elife | 2021 | 34009124 | PubTator, text mining | PubMed |
| Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children. | Xenobiotica | 2021 | 34000957 | PubTator, text mining | PubMed |
| Antiseizure Medication use in Gastric Bypass Patients and Other Post-Surgical Malabsorptive States. | Epilepsy Behav Rep | 2021 | 33997757 | PubTator, text mining | PubMed |
| Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism. | Front Pharmacol | 2021 | 33995083 | PubTator, text mining | PubMed |
| Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes. | Front Pharmacol | 2021 | 33995076 | PubTator, text mining | PubMed |
| Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. | Front Pharmacol | 2021 | 33981213 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Prediction of Mechanism of Shenzhuo Formula for Application to DKD. | Evid Based Complement Alternat Med | 2021 | 33968154 | PubTator, text mining | PubMed |
| Melissa officinalis L. as a Nutritional Strategy for Cardioprotection. | Front Physiol | 2021 | 33967832 | PubTator, text mining | PubMed |
| Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances. | Front Pharmacol | 2021 | 33967789 | PubTator, text mining | PubMed |
| CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar. | Front Pharmacol | 2021 | 33959023 | PubTator, text mining | PubMed |
| A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects. | Clin Pharmacol Drug Dev | 2021 | 33951339 | PubTator, text mining | PubMed |
| Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder. | Medicina (Kaunas) | 2021 | 33946323 | PubTator, text mining | PubMed |
| Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction? | Front Pharmacol | 2021 | 33935750 | PubTator, text mining | PubMed |
| Biochemistry of nicotine metabolism and its relevance to lung cancer. | J Biol Chem | 2021 | 33932402 | PubTator, text mining | PubMed |
| End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor. | CPT Pharmacometrics Syst Pharmacol | 2021 | 33932126 | PubTator, text mining | PubMed |
| Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection. | Pharmaceuticals (Basel) | 2021 | 33922522 | PubTator, text mining | PubMed |
| Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions. | Biomedicines | 2021 | 33922084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=31